Among Neisseria species, only N. meningitidis and N. gonorrhoeae are considered primary pathogens (8) . Strains of N. gonorrhoeae are always pathogenic, whereas strains of N. meningitidis, in addition to causing acute meningitis and septicemia, can also colonize the oro-and nasopharynx of a healthy carrier. Development of drug resistance in N. gonorrhoeae has led to concern about the almost inevitable increase of resistance in N. meningitidis (8) . Cephalosporins and fluoroquinolones are the two classes of antibiotics recommended for primary therapy (8) . Resistance to alternative therapy such as chloramphenicol for meningococcal infections (5) or spectinomycin for gonococcal infections (1) has been reported.
In gram-positive bacteria, resistance to spectinomycin, although much less common than resistance to other aminoglycoside-aminocyclitol antibiotics, is usually due to production of an aminoglycoside 9-O-nucleotidyltransferase of type I (9, 12) . Recently, a spectinomycin phosphotransferase has been reported for the gram-negative Legionella pneumophila (16) . In Escherichia coli, spectinomycin resistance has been shown to be due to mutations in helix 34 of 16S rRNA (15) . This helix consists of an upper and a lower stem separated by an internal loop containing two uracil residues.
We report mutations responsible for spectinomycin resistance in 16S rRNA genes of clinical isolates of N. meningitidis and N. gonorrhoeae.
Since 1988, surveillance of antibiotic resistance in clinical isolates of Neisseria spp. has been conducted at the National Center for Meningococci, Institut Pasteur, Paris, France, by disk-agar diffusion. Out of more than 16,800 clinical isolates, a single N. meningitidis isolate, LNP16311, and four N. gonorrhoeae isolates were found to be resistant to spectinomycin. The five strains of Neisseria spp. remained susceptible to penicillins, cephalosporins, tetracyclines, macrolides, rifamycins, and quinolones. Among the three N. gonorrhoeae strains isolated from urethritis patients in Gabon (LNP8205, Libreville, May 1989; LNP8919 and LNP8920, Franceville, March 1990), only strain LNP8205, as well as strain LNP9455, isolated from a urethritis patient in November 1990 at Saint Louis Hospital in Paris, was studied further.
N. meningitidis LNP16311, serogroup Y, was isolated in 1998 from the rhinopharynx of a 71-year-old male in Macon, France. A spectinomycin-resistant transformant, N. meningitidis BM4417, obtained after transformation of strain BM4377 (5, 13) with total DNA from LNP16311, was included in the study. Spectinomycin-susceptible N. meningitidis LNP15908 and BM4377 and N. gonorrhoeae LNP6910 were used as controls.
Total DNA from N. meningitidis LNP16311 and BM4417 and from N. gonorrhoeae LNP8205 and LNP9455 was transferred to nitrocellulose sheets (Nytran; Schleicher & Schuell, Dassel, Germany) and hybridized to 32 P-labeled ant(9)-I-and aph-specific probes (Radiochemical Centre, Amersham, England). Lack of hybridization suggested that spectinomycin resistance in these strains was not due to acquisition of known genes.
In structural models of E. coli 16S rRNA, spectinomycin resistance mutations are located in the upper stem of helix 34 ( Fig. 1) (7) , which is formed by base pairing of regions 1046 to 1067 and 1189 to 1211 (E. coli numbering [2, 3] ). Comparison of the sequence of 16S rRNA rrs genes from E. coli (GenBank accession no. V00348) to those of N. meningitidis (Sanger Centre; http://www.sanger.ac.uk/) indicated 79% identity with contig 407.
A region internal to rrs genes, including helix 34, of spectinomycin-susceptible and -resistant N. meningitidis and N. gonorrhoeae was explored by PCR using a DNA Thermal Cycler (model 2400; Perkin-Elmer Cetus, Norwalk, Conn.) and total DNA as a template. Two heptadecadeoxynucleotides (F.980, 5ЈCTTACCTGGTCTTGACA3Ј, and R.1353, 5ЈCGATTACT AGCGATTCC3Ј; E. coli numbering) designed from contig 407 and synthesized by the methoxy-phosphoramidite method (Unité de Chimie Organique, Institut Pasteur) allowed amplification of fragments with the predicted size (data not shown).
Double-stranded sequencing of the 373-bp PCR products was performed by the dideoxynucleotide chain termination method (14) with a T7 Sequenase PCR product sequencing kit (Amersham, Little Chalfont, Buckinghamshire, England), the 17-mer primers, and ␣- (6) , A1191C in N. tabacum chloroplast (17) , G1193A in Nicotiana undulata chloroplast (4), and G1064U,C,A in E. coli (3) , and of double mutations G1064U-C1192A, G1064C-C1192G, and G1064A-C1192U in E. coli (3) are indicated by circles.
of helix 34 (positions 1046 to 1067 and 1189 to 1211, E. coli numbering) from Neisseria strains was identical to that of E. coli except at position 1201, located in the lower stem of helix 34, where a transversion converted the adenine present in E. coli to a cytosine in Neisseria spp.
The sequence of helix 34 in the spectinomycin-resistant N. meningitidis clinical isolate LNP16311 differed from that of susceptible strain LNP15908 by a guanine-to-cytosine transversion at position 1064 (E. coli numbering [ Fig. 1] ). An identical substitution was found in the spectinomycin-resistant transformant BM4417 relative to BM4377. In both cases, the sequence of the amplification product obtained directly without cloning did not display any ambiguity (Fig. 2) . These data indicate that, like in LNP16311, each of the three rrs genes (10) in N. meningitidis BM4377 has been altered, an observation compatible with the small number of rrn operons in this species. Mutations at this position conferring spectinomycin resistance have been described for E. coli (G1064U,C,A [3] ) and Nicotiana tabacum chloroplast (G1064A [4] ).
Spectinomycin-resistant N. gonorrhoeae LNP8205 differed from susceptible LNP6910 by a cytosine-to-thymine transition at position 1192 (E. coli numbering [ Fig. 1 and data not  shown] ). Similar mutations conferring spectinomycin resistance have been described for E. coli (C1192U [15] and C1192U,G,A [11] ) and N. tabacum chloroplast (C1192U [17] ).
In conclusion, spectinomycin resistance in N. meningitidis and N. gonorrhoeae was due to mutations already found in the 16S rRNA genes. Spectinomycin alone is used in infections due to N. gonorrhoeae, in particular in the case of a high prevalence of ␤-lactamase-producing strains (1), and is likely to be responsible for emergence of resistance. The reason for the mutation in N. meningitidis, against which spectinomycin is not used, remains unknown.
